<DOC>
	<DOCNO>NCT01614041</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety comparative high dose Tandospirone Citrate treatment patient generalize anxiety disorder .</brief_summary>
	<brief_title>Tandospirone Citrate Treatment Patients With Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Tandospirone</mesh_term>
	<criteria>1865 year old Male female Diagnosed GAD accord DSMIV HAMA score≥17 Provide write informed consent Agree washedout two week receive SSRI , SNRI NASA . Serious suicidal tendency The score sixth item HAMA ≥3 The score HAMD ≥21 Pregnant lactate woman History allergic hypersensitivity tandospirone Serious unstable cardiac , renal , neurologic , cerebrovascular , metabolic , pulmonary disease Secondary anxiety disorder Drug alcohol dependence within 1 year Patients currently take benzodiazepine drug Drivers dangerous machine operator Participated clinical study last 30 day Patients clinically significant ECG laboratory abnormality Patients history epilepsy Patients abnormal TSH concentration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Generalized Anxiety Disorder</keyword>
</DOC>